Related Experiment Video
Updated: Mar 22, 2026
06:59
Quantification of Atherosclerosis in Mice
Published on: June 12, 2019
41.0K
Accelerated atherosclerosis and elevated lipoprotein (a) after liver transplantation
Abdulla A Damluji1, Diala El-Maouche2, Ali Alsulaimi1
1Cardiovascular Division and Elaine and Sydney Sussman Cardiac Catheterization Laboratories, University of Miami, Miller School of Medicine, Miami, FL, USA.
Journal of Clinical Lipidology
|April 9, 2016
Summary
Elevated lipoprotein(a) [Lp(a)] after liver transplant accelerated cardiovascular disease. Screening Lp(a) in transplant patients is crucial for preventing heart complications.
Area of Science:
- Cardiology
- Hepatology
- Genetics
Background:
- Lipoprotein(a) [Lp(a)] is a key driver of atherosclerotic cardiovascular disease.
- Lp(a) is synthesized and assembled extracellularly on hepatocytes.
Observation:
- A case study identified elevated Lp(a) post-orthotopic liver transplant.
- This elevation contributed to accelerated atherosclerosis despite treatment.
Findings:
- Orthotopic liver transplantation can lead to acquired hyperlipoprotein(a)emia.
- Acquired hyperlipoprotein(a)emia exacerbates cardiovascular risk in transplant recipients.
Implications:
- Routine Lp(a) screening for liver transplant donors and recipients is recommended.
- Early detection and management of Lp(a) can mitigate cardiovascular morbidity and mortality in transplant patients.
Related Concept Videos
01:30Atherosclerosis I: Introduction
1.9K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.9K
01:26Atherosclerosis III: Management
573
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
573
01:38Inflammation
64.0K
Overview
64.0K
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.7K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.7K
01:30Peripheral Artery Disease I: Introduction
593
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
593
01:30Coronary Artery Disease I: Introduction
1.6K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.6K